Cost-utility of vagus nerve stimulation (VNS) therapy for medically refractory epilepsy--an update.
Forbes
Raeburn
R
D000927:Anticonvulsants / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004351:Drug Resistance; D004599:Electric Stimulation Therapy / Q000191:economics* / Q000295:instrumentation / Q000639:trends; D004827:Epilepsy / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D006801:Humans; D018803:Models, Economic; D019057:Quality-Adjusted Life Years; D012640:Seizures / Q000453:epidemiology / Q000517:prevention & control; D014630:Vagus Nerve / Q000502:physiology*
D000927:Anticonvulsants